500 Participants Needed

Mindfulness-Based Sleep Program for Depression During Pregnancy

(STRIDE P Trial)

DA
CL
Overseen ByChristopher L Drake, PhD
Age: 18+
Sex: Female
Trial Phase: Phase 2
Sponsor: Henry Ford Health System
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to assist pregnant women experiencing insomnia (trouble sleeping) in preventing depression before and after birth. It tests a mindfulness-based sleep program called PUMAS (Perinatal Understanding of Mindful Awareness for Sleep), which combines sleep strategies and mindfulness exercises through online sessions. Participants will either try PUMAS or receive usual treatment options like sleep aids and therapy. Pregnant women between weeks 14 and 31, who have experienced trouble sleeping for over a month and have no major depression, might be suitable candidates. As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group of participants.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, it does mention that you should not be currently engaged in therapy for major depression or insomnia disorder.

What prior data suggests that the mindfulness-based sleep program is safe for pregnant women?

Research shows that the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) is generally well-tolerated by pregnant women with insomnia. In earlier studies, participants experienced better sleep and less depression and mental stress. No serious side effects were reported from PUMAS. This therapy uses mindfulness techniques, combining sleep strategies with meditation exercises specifically designed for pregnancy. Although researchers continue to study this treatment, it seems safe and shows promise in improving sleep and mental well-being.12345

Why are researchers excited about this trial?

Researchers are excited about the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) because it offers a new approach to managing prenatal insomnia, which is often treated with sleep aids, melatonin, or cognitive-behavioral therapy. PUMAS is unique because it combines behavioral sleep strategies with mindfulness exercises specifically tailored for pregnancy. Another exciting feature is its delivery method; PUMAS is conducted through telemedicine, making it accessible for expectant mothers who may have difficulty attending in-person sessions. This combination of tailored mindfulness and convenient access could significantly improve sleep quality for pregnant individuals experiencing depression.

What evidence suggests that the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) program might be an effective treatment for perinatal depression?

Research has shown that the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) program, which participants in this trial may receive, can significantly help pregnant women by reducing insomnia, depression, and mental restlessness. Women in studies who engaged with PUMAS experienced substantial improvements in sleep quality. The program combines simple sleep techniques with mindfulness exercises to reduce mental stress that can exacerbate sleep problems. Available through telemedicine, it offers expecting mothers easy and convenient access. Overall, PUMAS shows promise for improving sleep and may help lower the risk of depression during pregnancy.12356

Who Is on the Research Team?

DA

David A Kalmbach, PhD

Principal Investigator

Henry Ford Health

Are You a Good Fit for This Trial?

This trial is for pregnant women between weeks 14-31 who are not currently in therapy for major depression or insomnia, have no current severe depression or long-term insomnia disorder, and score moderately on the Insomnia Severity Index. They should not be at high risk of pregnancy complications nor work night shifts or plan extensive travel soon.

Inclusion Criteria

I am not currently receiving treatment for major depression or insomnia.
I do not have a current diagnosis of major depression.
I have been diagnosed with insomnia lasting more than a month.
See 4 more

Exclusion Criteria

I have Restless Leg Syndrome that hasn't been treated.
I do not have an uncontrolled sleep or mental disorder like narcolepsy or bipolar.
I often feel very sleepy during the day.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the PUMAS intervention or treatment-as-usual for prenatal insomnia, including six weekly 60-minute sessions delivered via telemedicine

8 weeks
6 visits (virtual)

Follow-up

Participants are monitored for changes in insomnia symptoms, cognitive arousal, and perinatal depression monthly for 1 year after childbirth

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Perinatal Understanding of Mindful Awareness for Sleep (PUMAS)
Trial Overview The study tests a mindfulness-based sleep program called PUMAS against usual treatment to see if it improves sleep and reduces cognitive arousal, potentially lowering the risk of perinatal depression during pregnancy and after birth.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Perinatal Understanding of Mindful Awareness for Sleep (PUMAS)Experimental Treatment1 Intervention
Group II: Treatment-as-usual (TAU)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Henry Ford Health System

Lead Sponsor

Trials
334
Recruited
2,197,000+

Published Research Related to This Trial

This study is testing a 6-week online mindfulness meditation program combined with cognitive-behavioral therapy for insomnia (CBT-I) to help pregnant women manage insomnia, with 50 participants recruited for a randomized controlled trial.
The primary goal is to assess the feasibility and efficacy of this intervention on sleep quality and mood, using various measures like the Pittsburgh Sleep Quality Index and daily sleep diaries, which could lead to a larger trial if successful.
Online prenatal trial in mindfulness sleep management (OPTIMISM): protocol for a pilot randomized controlled trial.Kantrowitz-Gordon, I., McCurry, SM., Landis, CA., et al.[2022]
The Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) program significantly reduced insomnia severity by an average of 10.83 points, leading to an 83.3% remission rate in a trial with 12 pregnant women, indicating its efficacy for treating prenatal insomnia.
PUMAS also effectively decreased symptoms of depression and cognitive arousal, with all five participants with comorbid depression achieving remission, showcasing its potential as a comprehensive treatment for pregnant women experiencing insomnia and related issues.
Perinatal Understanding of Mindful Awareness for Sleep (PUMAS): A single-arm proof-of-concept clinical trial of a mindfulness-based intervention for DSM-5 insomnia disorder during pregnancy.Kalmbach, DA., Cheng, P., Reffi, AN., et al.[2023]
The 'Perinatal Understanding of Mindful Awareness for Sleep' (PUMAS) program significantly improved mindfulness and maternal-fetal attachment in 11 pregnant women with insomnia, indicating its potential benefits beyond just sleep improvement.
Participants also experienced substantial reductions in anxiety, repetitive thinking, and sleep-related daytime impairment, suggesting that PUMAS may enhance overall maternal well-being during pregnancy.
Preliminary evidence of psychological improvements and increased maternal-fetal attachment associated with a mindfulness sleep programme: secondary analysis of uncontrolled data in 11 pregnant women with insomnia disorder.Kalmbach, DA., Reffi, AN., Ong, JC., et al.[2023]

Citations

Perinatal Understanding of Mindful Awareness for Sleep ...Prenatal insomnia patients were highly engaged in PUMAS, which produced large acute reductions in insomnia, depression, and cognitive arousal. These findings ...
A single-arm proof-of-concept clinical trial of a mindfulness ...Therapies aimed at reducing cognitive arousal may benefit pregnant women with insomnia. This proof-of-concept trial evaluated Perinatal Understanding of Mindful ...
Telemedicine Mindfulness-based Therapy for Perinatal ...The purpose of this research study is to examine the effectiveness of a mindfulness-based intervention for prenatal insomnia via telemedicine format to improve ...
A single-arm proof-of-concept clinical trial of a mindfulness ...Perinatal Understanding of Mindful Awareness for Sleep (PUMAS): A single-arm proof-of-concept clinical trial of a mindfulness-based intervention for DSM-5 ...
Reducing nocturnal cognitive arousal is a treatment ...CBTI and PUMAS are effective for prenatal insomnia, even in women with comorbid OSA. PUMAS may be especially beneficial for pregnant women presenting with PND.
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37343335/
A single-arm proof-of-concept clinical trial of a mindfulness ...This proof-of-concept trial evaluated Perinatal Understanding of Mindful Awareness for Sleep (PUMAS, which combines mindfulness with behavioral sleep ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security